João Amílcar SalgadoI; Cid Veloso
Professor em dedicação exclusiva
RESUMO
O estudo de 911 pacientes hospitalizados para tratamento de variados casos de patologia interna mostrou 26,8% de hipertensos e 34,7% de doentes com alteração hepática, 17,7% dêstes apresentando hepatopatia esquistossomótica. A análise das observações resultem, na seleção de seis casos em que havia a coexistência de hipertensão e hepatopatia e que são estudados em separado. Outros seis casos foram encontrados em que a necrópsia revelou alteração hepática e o “rim da hipertensão essencial”, mas em cujas observações clinioas não constava qualquer evidência de doença hipertensiva. A comparação da média das pressões arteriais mostrou diferença estatisticamente significante para as pressões sistólicas e diastólicas, sendo mais altas entre os pacientes não hepatopatas. Fêz-se, também, minuciosa revisão da literatura.
ABSTRACT
Studying 911 patients hospitalized for the treatment of unselected cases of intertal pathology, the authors observed 26,8% of hypertensive cases and 34,7% of patients with liver disease, from which 17,7% showed schistosomal liver involvement. The analysis resulted on selecting six cases, where the coexistence of hypertension and liver disease was noticed. Another group of nine cases was found whose necropsy revealed liver pathology and the so called “essential hypertension kidney”, not disclosed by clinicai examination. The comparison of means showed a significant difference suggesting a higher blood pressure among patients without liver disease.
Texto completo disponível apenas em PDF.
Full text available only in PDF format.
BIBLIOGRAFIA
1. ABELMANN, W. H., KOWALSKI, H. J. & McNEELY, W. F. – The hemodynamic response to exercise in patients with Laennec’s cirrhosis. J. Clin. Invest. 34: 690-695, 1955. [ Links ]
2. AMES, R. P., BORKOWSKI, A. J., SICINSKI, A. M. & LARAGH, J. H. – Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, and aldosterone and cortisol secretion in normal man and cirrhosis with ascites. J. Clin. Invest. 44: 1171-1186, 1965. [ Links ]
3. BAXTER, J. H. & ASHWORTH, C. T. – Renal lesions in portal cirrhosis. Arch. Pathol. 41: 476-488, 1946. [ Links ]
4. BERTHELOT, P., WALKER, J. G., SHERLOCK, S. & REID, L. – Arterial changes in the lung in cirrhosis of the liver – lung spider nevi. New England J. Med. 274: 291-298, 1966. [ Links ]
5. BIRON, P., BALDUS, W. P. & SUMMERSKILL, W. H. J. – Plasma angiotensinase activity in cirrhosis. Proc. Soc. Exp. Biol. Med. 116: 1074-1077, 1964. [ Links ]
6. BIRON, P., KOIW, E., NOWACZINSKI, W., BROTJILLET, J. & GENEST, J. – The effects of intravenous infusions of valine – 5 angiotensin II and other pressor agents on urinary electrolytes and corticosteroids including aldosterone. J. Clin. Invest. 40: 338-347, 1961. [ Links ]
7. BLALOCK, A. & LEVY, S. E. – Gradual complete occlusion of celiac axis, superior and inferior mesenteric arteries, with survival of animais: effects of ischemia on blood pressure. Surgery 5: 175-178, 1939. [ Links ]
8. BOCKUS, H. L. – Gastroenterology. – Second edition. – Volume III. – Philadelphia, W. B. Saunders Company, 1965. [ Links ]
9. BRAUN-MENENDEZ, E., FASCIOLO, J. C., LELOIR, L. F. & MUNOZ, J. M. – La substancia hipertensora de la sangre dei rinon isquemiado. Rev. Soc. Argent. Biol.. 15: 420-425, 1939. [ Links ]
10. CARPENTER, C C. J DAVIS, J. O., & AYRES, C. R. – Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion. J. Clin. Invest. 40: 2026- 2042, 1961. [ Links ]
11. CARPENTER, C. C. J., DAVIS, J. O., HÒLMAN, J. E., AYERS, C. R. & BAHN, R. C. – Studies on the response of the transplanted kidney and the transplanted adrenal gland to thoracic inferior vena cavai constriction. J. Clin. Invest. 40: 196-204, 1961. [ Links ]
12. CARRIÈRE, G. & GÉRARD, E. – De l’action hypotensive du cholalate de soude. Bull. Acad. Med. 107: 443-445, 1932. [ Links ]
13. CHAMBERLAIN, M. J., BROWZE, N. L GIBSON, D. G. & GLEESON, J. A. – Angiotension and reno-portal anastomosis. Brit. Med. J. 2: 1507- 1508, 1964. [ Links ]
14. CHAUFFARD, A. – Traité de Medicine III. Maladies du Poie. Paris, 1892, p. 691 (apud Daniel20). [ Links ]
15. CHILD, C. G. & GLENN, P. – Effect of passing renal blood through liver in dogs with experimental hypertension. Arch. Surg. 36: 376-380, 1938. [ Links ]
16. CIRKSENA, W. J., DIRKS, J. H. & BERLINER. R. W. – Effect of thoracic cava obstruction on response of proximal tubule sodium reabsorption to saline infusion. J. Clin. Invest. 45: 179-186, 1966. [ Links ]
17. CLAYPOOL, J. G., DELP, M. & LIN, T. K. – Hemodynamic studies in patients with Laennec’s cirrhosis. Am. J. M. Sc. 234: 48-55, 1957. [ Links ]
18. COHEN, E. L RORNER, D. R. & CONN, J. W. – Postural augmentation of plasma renin activity. Importance in diagnosis of renovascular hypertension. J. Amer. Med. Ass. 197: 973-978, 1966. [ Links ]
19. DAHL, L. K. – Metabolic aspects of hypertension. Ann. Rev. Med. 14: 69-98, 1963. [ Links ]
20. DANIEL, I. – Considérations sur le rôle d’un facteur hépatobiliaire dans la génèse de l’hypertension artérielle essentielle (humorale). Gaz. Med. France. 70: 467-474, 1963. [ Links ]
21. DAVIS, J. O., HARTROFT, P. M., TITUS, E. O., CARPENTER, C. C. J., AYERS, C. R. & SPIEGEL, H. E. – The role of the renin-angiotension system in the control of aldosterone secretion. J. Clin. Invest. 41: 378- 389, 1962. [ Links ]
22. DAVIS, L. & TANTURI, C. A. – Liver as a factor in experimental renal hypertension. Arch. Surg. 62: 325- 334, 1951. [ Links ]
23. DAVIS, L., TANTURI, C. A. & TARKINGTON, J. – The effect of reduced blood flow to the liver in renal hypertension. Surg. Gynecol. and Obst. 89: 360-361, 1949. [ Links ]
24. EDITORIAL – Hypertension and hepatic cirrhosis. Brit. Med. J. 1: 1032, 1956. [ Links ]
24. EDMONDSON, H. A., PETERS, R. L., FRANKEL, H. H. & BOROWSKY, S. – The early stage of liver injury in the alcoholic. Medicine 46: 119-129, 1967. [ Links ]
26. EPPINGER, H. – Enfermedades dei hígado – Traducción. Buenos Aires, Editorial Labor, 1940. [ Links ]
27. FISHBERG, A. M. – Hypertension and nephritis. Fifth adition. Philadelphia, Lea & Febiger, 1954. [ Links ]
28. FISHER, E. R., HELLSTROM, H. R. & FISHER, B. – Ràrity of hepatic metastases in cirrhosis – a misconception. J. Amer. Med. Ass. 174: 366-369, 1960. [ Links ]
29. FRANK, .A., SELIGMAN, A. M. & FINE, J. – Traumatic shock. XIII: The prevention of irreversibility in hemorrhagic shock by viviperfusion of the liver. J. Clin. Invest. 25: 22- 29, 1946. [ Links ]
30. FRITTS, H. W., Jr. – Systemic Circulatory Adjustments in Hepatic Disease. Med. Clin. N. Amer. 47: 563- 578, 1963. [ Links ]
31. GALENO apud Fritts30.
32. GANT, C. L. – Pathophysiology of hipertension. Med. Clin. N. Amer. 51: 3-14, 1967. [ Links ]
33. GENEST J., BIRON, P., CHERETIEN, M BOUCHER, R., KOIW, E. – Blood angiotensin leveis in normal subjects and hypertensive patients. J. Clin. Invest. 41: 1360-1361, 1962. [ Links ]
34. GOLDBLATT, H., LYNCH, J HANZAL, R. F. & SUMMERVILLE, W. W. – Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59: 347-379, 1934. [ Links ]
35. GOODMAN, L. S. & GILMAN, A. – The Pharmaeological basis of therapeutics. Third Edition. New York, The Macmillan Company, 1965. [ Links ]
36. GRANT, W. C., WASSERMANN, F., RODENSKY, P. L. & THOMPSON, R. V. – The incidence of myocardial infarction in portal cirrhosis. Ann. Intern. Med. 51: 774-779, 1959. [ Links ]
37. HANSOTI, R. C. & SHAH, N. J. – Cirrhosis of liver simulating congenital cyanotic heart disease. Circulation. 33: 71-77, 1966. [ Links ]
38. HARINASUTA, U CHOMET, B ISHAK, K. & ZIMMERMAN, H. J. – Steatonecrosis – Mallary body type. Medicine. 46: 141-162, 1967. [ Links ]
39. HAYNES, F. W. & DEXTER, L. – The hypertensionogen concentration of the plasma of patients with various diseases. Federat. Proc. 2: 20, 1943. [ Links ]
40. HECKER, R. & SHERLOCK, S. – Electrolyte and circulatory changes in terminal liver failure. Lancet 2: 1121-1125, 1956. [ Links ]
41. HEINEMANN, H. O. – Respiration and circulation in patients with portal cirrhosis of the liver. Circulation, 22: 154-159, 1960. [ Links ]
42. HOWELL, W. L. & MANION, W. C. – The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17.731 autopsies. Amer. Heart. J. 60: 341, 1960. [ Links ]
43. ITSKOVITZ, H. D., DUDRICK, S. J., DYRDA, I. & MURPHY, J. L. – Plasma angiotensinase activity in hypertensive patients. Arch. intern. Med. 119: 241-246, 1967. [ Links ]
44. KARETZKY, M. S. & MITHOEFER, J. C. – The cause of hypertentilation and arterial hynoxia in patients with cirrhosis of the liver. Amer- J. Med. Sci. 254: 797-804, 1967. [ Links ]
45. KIRSCHBAUM, J. D. & SHURE, N. – Alcoholic cirrhosis of the liver – a clinicai and pathologic study of 356 fatal cases selected from 12267 necropsies. J. Lab. Clin. Med. 28: 721- 731, 1943. [ Links ]
46. KLAUS, D., KAFFARNIK, H. & PFEIL, H. – Untersuchungen uber die Serum-Angiotensinase. II. Mitteilung. Klinische Ergenisse beim Hochdruck und bei Leberer Krankungen. Klin. Wschr. 41: 380-385, 1963. [ Links ]
47. KOWALSKI, H. J. & ABELMANN, W. H. – The cardiac output at rest in Laennec’s cirrhosis. J. Clin. Invest. 32: 1025-1033, 1953. [ Links ]
48. KOWALSKI, H. J., ABELMANN, W. H. & McNEELY, W. F. – The cardiac output in patients with cirrhosis of the liver and tense ascites, with observations on the effect of paracentesis. J. Clin. Invest. 33: 768-773, 1954. [ Links ]
49. LANCESTREMORE, R. G. DAVIDSON, P. L., EARLEY, L. E., O’ BRIEN, F. J. & PAPPER, S. – Renal failure in Laennec’s cirrhosis. II. Simultaneous determination of cardiac output and renal hemodynamics. J. Clin. Invest. 41: 1922-1927, 1962. [ Links ]
50. LARAGH, J. H. – Interrelationships between angiotensin, norepinephrine, epinephrine, aldosterone secretion, and electrolyte metabolism in man. Circulation, 25: 203-211, 1962. [ Links ]
51. LARAGH, J. H. – Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Federat. Proc. 26: 39-41, 1967. [ Links ]
52. LARAGH, J. H. & AMES, R. P. – Physiology of body water and electrolytes in hepatic disease. Med. Clin. N. Amer. 47: 587-, 1063. [ Links ]
53. LARAGH, J. H., CANNON, P. J. & AMES, R. P. – Internaction between aldosterone secretion, sodium and potassium balance, and angiotensin activity in man: Studies in hypertension and cirrhosis: canad. Med. Ass. J. 90: 248-256, 1964. [ Links ]
54. LELOIR, L. F., MUÑOZ, J. M., TAQUINI, A. C., BRAUN-MENENDEZ, E. & FASCIOLO, J. C. – La formacion dei hypertensinogeno. Rev. argent. Cardiol. 9: 269-278, 1942. [ Links ]
55. LEMIERRE, A., LENORMANT, C., PAGNIEZ, P., SAVY, P., FIESSINGER. N., GENNES, L. & RAVINA, A. – Traité de Médicine. Tome VIII, Paris, Masson, 1948. [ Links ]
56. LICHTMAN, S. S. – Diseases of the liver, gallbladder and bile duets. Third edition. Philadelphia, Lea & Febiger, 1953. [ Links ]
57. LOYKE, H. F. – Relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Amer. J. Med. Sci. 230: 627-632, 1955. [ Links ]
58. LOYKE, H. F. – Reduction of hypertension after liver disease. Arch. intern. Med., 110: 45-49, 1962. [ Links ]
59. LOYKE. H. F. – Hypertension and liver disease: a clinicai and experimental review. Amer. J. Gastroent. 38: 56-89, 1962. [ Links ]
60. LOYKE, H. F. & CUTARELLI, R. – An evaluation of hypertension and liver disease in an alcoholic Service. Amer. J. Med. Sci. 240: 346-348, 1960. [ Links ]
61. LOYKE, H. F. & MACKRELL, J. S. – Effect of liver damage on experimental desoxycorticosterone hypertension in the rat. J. Lab. Clin. Med. 58: 871-875, 1961. [ Links ]
62. LOYKE, H. F., PLUCINSKI, J. J. & CRAWFORD, T. L. – Effect of liver damage on experimental renal hypertension in the rat. Circulat. Res. 8: 535, 1960 (apud Loyke58). [ Links ]
LUNSETH, J. H., OLMSTEAD, E. G. & ABBOUD, F. – A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. Arch. intern. Med. 102: 405-413, 1958. [ Links ]
64. MAINLAND, D. – The risk of fallacious conclusions from autopsy data on the incidence of diseases with apnlications to heart disease. Amer. Heart. J. 45: 644-654, 1953. [ Links ]
65. MASHFORD, M. L., MAHON, W. A. & CHALMERS, T. C. – Studies of the cardiovascular system in the hypotension of liver failure. New England J. Med. 267: 1071-1074, 1962. [ Links ]
66. MASTER, A. M., GARFIELD, C. I. & WALTERS, M. B. – Normal blood pressure and hypertension. New definitions. philadelphia, Lea & Febiger, 1952. [ Links ]
67. McGIFF. J. C. – The natriuretic effect of angiotensin revealed after sutonomic blockade. J. Clin. Invest. 45: 1044-1045, 1966. [ Links ]
68. MEAKINS, C. – Jaundice an blood pressure. Med. Clin. N. Amer. 16: 715, 1932 (apud Daniel20) . [ Links ]
69. MEIRA, J. A. – Quadro clínico da esquistossomose mansônica. R. Bras. Malariol. e Doenc. trop. 11: 247-357, 1959. [ Links ]
70. MILLER, L. L. & BALE, W. F. – Synthesis of ali plasma protein fractions except gamma globulins by the liver. The use of zone electrophoresis and lysine – E-C14 to define the plasma proteins synthetized by the isolated perfused liver. J. Exp. Med. 99: 125, 1954. [ Links ]
71. MUIRHEAD, E. E., BROOKS, B., KOSINSKI, M., DANIELS, E. G. & HINMAN, J. W. – Renomedullary antihypertensive principie in renal hypertension. J. Lab. Clin. Med. 67: 778-791, 1966. [ Links ]
72. MULHAUSEN, R. EICHENHOLZ, A. & BLUMENTALS, A. – Acid-base disturbances in patients with cirrhosis of the liver. Medicine, 46: 185- 189, 1967. [ Links ]
73. MURRAY, J. F., DAWSON, A. M. & SHERLOCK, S. – Circulatory changes in chronic liver disease. Amer. J. Med. 24: 358-367, 1958. [ Links ]
74 NASSIF, A. C., NOLAN, T. R. & CORCORAN, A. C. – Angiotensin II in treatment of hypotensive states. J. Amer. Med. Ass. 183: 751- 757, 1963. [ Links ]
75. NIJENSOHN, C. M. in Semana Med. (Buenos Aires) 3: 205, 1957 (apud Dahl19) . [ Links ]
76. 0’HARE, J. P., CALHOUN, A. W. & ALTNOW, H. O. – Etiology of chronic myocarditis. J. Amer. Med. Ass. 90: 1436-1438, 1928. [ Links ]
77. OPPENHEIM, M. – Die Myokardose bei Lebercirrhose. Schweiz. Med. Wschr. 80: 795, 1950 (apud Bockus8). [ Links ]
78. OSSERMAN, E. F. & TAKATSVKI, K. – The plasma proteins in liver disease. Med. Clin. N. Amer. 47: 679-710, 1963. [ Links ]
79. PAGE, I. H. – Influence of the liver on vascular reactivity. Amer. J. Physiol. 160: 421-436, 1950. [ Links ]
80. PAGE, I. H. – Neural and humoral eontrol of blood vessels, in Ciba Foundation Symposium on Hypertension. London. Churchill, 1954 (pp. 3-30) . [ Links ]
81. PAGE, I. H. McSWAIN, B., KNAPP, G. M. & ANDRUS, W. D. – The origin of renin-activator. Am. J. Physiol. 135: 214-222, 1941. [ Links ]
82. PATEK, A. J., Jr., SEEGAL, D. & BEVANS, M. – The coevistence of cirrhosis of the liver and glomerulo- nephritis. Amer. J. Med. Sci. 221: 77-85, 1951. [ Links ]
83. PERERA, G. A. – Hypertensive disease without hypertension, in Ciba Foundation Symposium on Hypertension. London, Churchill, 1954 (pp. 46-57). [ Links ]
84. RAASCHOU, F. – Liver funetion and hypertension: blood pressure and heart weight in chronic hepatitis. Circulation, 10: 511-516, 1954. [ Links ]
85. RAASCHOU, F. & TRAUTNER, K. – Obstruction of the common bile duet in experimental renal hypertension in dogs. Scand. J. Clin. Lab. Invest. 5: 223-235, 1953. [ Links ]
86. ROCHA E SILVA, M. – Angiotensin and bradikinin: a study in contrasts. Canad. Med. Ass. J. 90: 307-311, 1964. [ Links ]
87. RUEBNER, B. H., GREEN, R., MIYAL, K., CARANASOS, G. & ABBEY, H. – Te rarity of intrahepatic metastasis in cirrhosis of the liver. Amer. J. Pathol. 39: 739-746, 1961. [ Links ]
88. RUEBNER, B. H., MIYAL, K. & ABBEY, H. – The low incidence of myocardial infarction in hepatic cirrhosis. – a statistical artefact? Lancet 2: 1435-1436, 1961. [ Links ]
89. RYDELL, R. & HOFFEAUER, F. W. – Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Amer. J. Med. 21: 450-460, 1956. [ Links ]
90. SCHMITT, W. & PIPPIG, L. – Leberdurchbíutuns; bei Hypertonie. Z. Klin. Med. 157: 176-183, 1962. [ Links ]
91. SCHWAB, E. H. & DOLPH, L. C. – A note on the diagnosis of hypertensive cardiovascular disease without hypertension. J. Lab. Clin. Med. 24: 125-127, 1938. [ Links ]
92. SCHWARTZ, D. T. – Relation of superior – mesenteric – artery obstruction to renal hypertension. A review of 56 cases. New Eng. J. Med. 272: 1318-1321, 1965 . [ Links ]
93. SCHWARTZ, D. T. – The effect of portacaval transposition on the inactivation of angiotensin by the canine liver. Ann Surg. 166: 157-160, 1967. [ Links ]
94. SCHWARTZ, D. T. – The relation of cirrhosis of the liver to renal hypertension. A review of 639 autopsied cases. Ann. Intern. Med. 66: 862- 869, 1967. [ Links ]
95. SCHWARTZ, D. T., McCABE, R. E., Jr. & ZINTEL, H. A. – The effect of portacaval transposition on renal hypertension in the dog. Surg. Gynecol. and Obst. 122: 317-325, 1966. [ Links ]
96. SHALABY, E. S., ZAKI, S. A. & FAHMY, S. A. – Incidense of atherosclerosis, hypertension & myoeardial infarction in bilharzial cirrhosis: J. Egypt. Med. Ass. 46: 53, 1963. [ Links ]
97. SHORR, E. – Hepatorenal factors in essencial hypertension in man, in Bell, E. T., Clawson, B. J. & FAHR, G. E. – Hypertension, Minneapolis, University of Minnesota Press, 1951 (pp. 265-282) . [ Links ]
98. SHORR, E., ZWEIFACH, B. W. & FURCHGOTT – On the occurrence, sites and modes of origin and destruction of principies affecting the compensatory vascular mechanisms in experimental shock. Science 102: 489-498, 1945. [ Links ]
99. SXEGGS, L. T., LENTZ, K. E., GOULD, A. B., HOCHSTRASSER, H. & KAHN, J. R. – Biochemistry and kinstics of the renin-angiotensin. system. Federat. Proc. 26: 42-47, 1967. [ Links ]
100. SNELL, A. M. – Effects of chronic disease of the liver on the composition and physiochemical properties cf blood: Changes in the serum proteins: Reduction in the oxygen saturation of the arterial blood. Ann. intern. Med. 9: 690-711, 1935. [ Links ]
101. SPATT, S. D. & ROSENBLATT, P. – The incidence of hypertension in portal cirrhosis: A study of 80 necropsied cases of portal cirrhosis. Ann. intern. Med. 31: 479-483, 1949. [ Links ]
102. STRAUSS, M. B. & WELT, L. G. – Diseases of the kidney. Boston, Little, Brown & Company, 1963. [ Links ]
103. TABATA, F. – Role of the liver in experimental renal hypertension. Study on inactivating ability of the vasoactive substance following renoportal venous anastomosis. Kobe J. Med. Sci. 9: 93-134, 1963. [ Links ]
104. TOBLAN. L. SCHONNING, S. & SEEFELDT, C. – Influence of arterial pressure on the antihypertensive action of a normal kidney, a biological servomechanism. Ann. intern. Med. 60: 378-383, 1964. [ Links ]
105. VELOSO, C., SALGADO, J. A. & MACEDO, R. – Redução da hipertensão arterial na esquistossomose mansoni hepatosplênica. R. Ass. Med. M. Gerais. 19: 80-84, 1967. [ Links ]
106. VORHAUS, C. J. – Blood pressure leveis and abnormalities in cirrhosis of the liver. Ann. intern. Med. 51: 290-300, 1959. [ Links ]
107. ZWEIFACH, B. W. – Evaluation of hepatic factors in hypertension, in Hypertension. The First Hahnemann Symposium on Hypertensive Disease. Philadelphia Saunders, 1959 (Pp. 192-196). [ Links ]
Recebido para publicação em 10.6.71.
Trabalho da Disciplina de Semiologia (Titular Prof. João Galizzi), da Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.
